Neuroscience Institute, Section of Cagliari, National Research Council of Italy, I-09042 Monserrato, Italy.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Alcohol Alcohol. 2022 Nov 11;57(6):706-711. doi: 10.1093/alcalc/agac026.
A recent study reported how acute treatment with KK-92A, a newly synthesized positive allosteric modulator (PAMs) of the GABAB receptor (GABAB PAMs), suppressed a series of alcohol-related behaviors, including operant oral alcohol self-administration, in selectively bred Sardinian alcohol-preferring (sP) rats. These findings lead to the addition of KK-92A to the long list of GABAB PAMs capable of reducing, after acute treatment, alcohol self-administration in rats. As a further step toward a more complete characterization of the anti-addictive properties of KK-92A, the present study was designed to assess the effect of repeated treatment with the compound on alcohol self-administration.
sP rats were trained to lever-respond for oral alcohol (15%, v/v) under the fixed ratio 5 (FR5) schedule of reinforcement. Once lever-responding behavior had stabilized, KK-92A (0, 5, 10 and 20 mg/kg, i.p.) was administered 30 min prior to 10 consecutive daily self-administration sessions (likewise occurring under the FR5 schedule).
The first injection of KK-92A produced a dose-related suppression in number of lever-responses for alcohol and amount of self-administered alcohol. Magnitude of the suppressing effect of KK-92A decreased over the following two self-administration sessions and then tended to stabilize on continuation of treatment. Statistical significance at post hoc analysis was maintained only by the highest dose tested (20 mg/kg).
These data suggest the development of partial tolerance to the reducing effect of repeatedly administered KK-92A on alcohol self-administration. The agonistic component of the ago-allosteric profile of KK-92A is discussed as the likely key element underlying the observed tolerance.
最近的一项研究报告了新型 GABAB 受体(GABAB PAMs)正变别构调节剂(PAMs)KK-92A 的急性治疗如何抑制一系列与酒精相关的行为,包括选择性培育的撒丁岛酒精偏好(sP)大鼠的操作性口服酒精自我给药。这些发现使得 KK-92A 被添加到能够在大鼠中减少急性治疗后酒精自我给药的长串 GABAB PAMs 中。作为对 KK-92A 抗成瘾特性进行更全面表征的进一步步骤,本研究旨在评估该化合物重复治疗对酒精自我给药的影响。
sP 大鼠在固定比率 5(FR5)强化方案下训练对口服酒精(15%,v/v)进行杠杆反应。一旦杠杆反应行为稳定,在 10 次连续的自我给药(同样在 FR5 方案下进行)之前 30 分钟给予 KK-92A(0、5、10 和 20 mg/kg,ip)。
首次注射 KK-92A 导致酒精的杠杆反应次数和自我给药量呈剂量相关抑制。KK-92A 抑制作用的幅度在前两次自我给药期间减少,然后在继续治疗时趋于稳定。在事后分析中仅维持了最高测试剂量(20 mg/kg)的统计学意义。
这些数据表明,反复给予 KK-92A 对酒精自我给药的减少作用产生了部分耐受。KK-92A 的激动性变构特征的激动成分被认为是观察到的耐受性的关键因素。